Transdermal CBD no better than placebo for drug-resistant focal epilepsy
For adults with drug-resistant focal epilepsy, no difference in efficacy was observed at 12 weeks for adjunctive therapy with transdermal cannabidiol versus placebo, according to a study published online July 8 in JAMA Network ...
Jul 18, 2022
0
11